SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Kirsten who wrote (561)4/6/1998 7:16:00 PM
From: yosi s  Respond to of 1491
 
PARS tamoxiphen derivative. is 1 theoretically more active.

In animal model.

2. Offers same protection against osteoporosis
3. less uterine effect.

all in all in theory it is better.

it takes phase 1 2 3 studies to prove it.

it is a very good pipeline drug

that is why I like PARS

Also today Neuroinvstor very + report will give synopsis later.